Gerardo Guillén Selected Research

Infections

1/2023	Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB/c mice.
6/2017	The tetravalent formulation of domain III-capsid proteins recalls memory B- and T-cell responses induced in monkeys by an experimental dengue virus infection.
1/2016	Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune response.
8/2015	A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys.
7/2014	Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus.
7/2014	Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
12/2013	Olive baboons: a non-human primate model for testing dengue virus type 2 replication.
6/2012	Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice.
3/2011	The chimeric protein domain III-capsid of dengue virus serotype 2 (DEN-2) successfully boosts neutralizing antibodies generated in monkeys upon infection with DEN-2.
12/2009	Viremia and the magnitude of the immune response upon infection of green monkeys with dengue virus type 2 are strain-dependent.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerardo Guillén Research Topics

Disease

28	Dengue (Dengue Fever) 01/2016 - 08/2003
11	Infections 01/2023 - 01/2008
5	Viremia 01/2019 - 08/2003
3	COVID-19 01/2022 - 02/2021
3	Neoplasms (Cancer) 02/2021 - 12/2005
3	Virus Diseases (Viral Diseases) 06/2017 - 02/2010
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2008
2	Viral Encephalitis 01/2016 - 04/2009
2	Encephalitis (Encephalitis, Rasmussen) 01/2016 - 01/2013
2	Necrosis 06/2012 - 02/2007
1	Vesicular Stomatitis 06/2023
1	Pneumonia (Pneumonitis) 02/2021
1	Severe Dengue 01/2019
1	Hepatitis B 01/2018
1	Reinfection 06/2017
1	Meningococcal Infections 02/2010
1	Breast Neoplasms (Breast Cancer) 01/2008
1	Myocardial Infarction 02/2007
1	Body Weight (Weight, Body) 02/2007
1	Coronary Occlusion 02/2007
1	Ulcer 09/2006
1	Diabetic Foot 09/2006
1	Wounds and Injuries (Trauma) 09/2006
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2005

Drug/Important Bio-Agent (IBA)

24	VaccinesIBA 01/2022 - 08/2003
21	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2003
9	Neutralizing AntibodiesIBA 01/2019 - 08/2003
9	Capsid Proteins (Capsid Protein)IBA 06/2017 - 01/2007
7	AntibodiesIBA 06/2023 - 08/2003
7	Recombinant ProteinsIBA 07/2014 - 01/2008
5	Antiviral Agents (Antivirals)IBA 06/2017 - 01/2007
5	Recombinant Fusion ProteinsIBA 07/2012 - 04/2006
4	Dengue VaccinesIBA 07/2014 - 04/2009
3	AntigensIBA 01/2023 - 01/2013
3	Carrier Proteins (Binding Protein)IBA 06/2011 - 02/2009
2	Peptides (Polypeptides)IBA 02/2021 - 12/2005
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2019 - 01/2008
2	Interferon-gamma (Interferon, gamma)IBA 07/2014 - 06/2012
2	Combined VaccinesIBA 07/2014 - 06/2012
2	Viral AntigensIBA 07/2012 - 12/2008
2	EpitopesIBA 07/2012 - 12/2008
2	Immunoglobulin M (IgM)IBA 01/2008 - 08/2003
2	Amino Acids FDA Link 10/2006 - 01/2004
1	Subunit VaccinesIBA 12/2021
1	Protein Kinases (Protein Kinase)IBA 02/2021
1	Testosterone (Sustanon)FDA Link 01/2019
1	aluminum sulfate (alum)IBA 01/2015
1	OligodeoxyribonucleotidesIBA 01/2015
1	Interferon Type IIBA 07/2014
1	Immunoglobulin G (IgG)IBA 07/2012
1	CytokinesIBA 06/2012
1	Polysaccharides (Glycans)IBA 05/2012
1	Indicators and Reagents (Reagents)IBA 12/2009
1	Hormones (Hormone)IBA 01/2008
1	AndrogensIBA 01/2008
1	Oxidants (Oxidizing Agents)IBA 02/2007
1	Saline SolutionIBA 02/2007
1	gamma- aminobutyryl- 2- methyltryptophyl- 2- methyltryptophyl- 2- methyltryptophyl- lysinamideIBA 02/2007
1	Epidermal Growth Factor (EGF)IBA 09/2006
1	Glycoproteins (Glycoprotein)IBA 08/2003

Therapy/Procedure

1	Therapeutics 01/2019
1	Surgical Amputation (Amputations) 09/2006
1	Immunotherapy 12/2005